<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Diphenhydramine - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Diphenhydramine</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Respiratory / Allergy</div>
      <h1>Diphenhydramine</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Diphenhydramine 25mg Capsules</li>
          <li>Diphenhydramine 50mg/mL Injection 1mL</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Allergic reaction / urticaria</strong> (symptom relief; NOT first-line for life-threatening anaphylaxis)</p>
        <ul>
          <li>PO: 25–50 mg every 4–6 hours as needed</li>
          <li>IM/IV: 25–50 mg as a single dose (typical), may repeat per protocol/medical direction</li>
        </ul>
        <p><strong>Adjunct for anaphylaxis</strong> (itching/urticaria only; AFTER epinephrine when indicated)</p>
        <ul>
          <li>IM/IV: 25–50 mg (common)</li>
        </ul>
        <p><strong>Motion sickness / vestibular nausea</strong> (if used)</p>
        <ul>
          <li>PO: 25–50 mg every 4–6 hours as needed (sedating)</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Allergic symptoms (urticaria, pruritus, mild allergic reactions)</li>
          <li>Adjunct symptom control in anaphylaxis (does not treat airway/shock)</li>
          <li>Motion sickness / vertigo-associated nausea (sedating option)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to diphenhydramine/antihistamines</li>
          <li>Significant sedation/impairment: avoid driving/operating machinery</li>
          <li>Anticholinergic cautions: narrow-angle glaucoma, urinary retention/BPH, severe constipation/ileus risk</li>
          <li>Additive CNS depression with alcohol, opioids, benzodiazepines, other sedatives</li>
          <li>IV administration: avoid rapid IV push; hypotension and excessive sedation risk (follow local protocol)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>PO: take with water; onset may be slower than parenteral routes</li>
          <li>IM/IV: give per protocol; monitor closely for sedation/hypotension</li>
          <li>Avoid dosing errors in frail/older adults (delirium/oversedation risk)</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Mental status/sedation, respiratory status (if co-sedatives used)</li>
          <li>BP/HR (especially if IV)</li>
          <li>Symptom response (itching/hives), progression of allergic reaction</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Drowsiness/sedation, dizziness</li>
          <li>Dry mouth, blurred vision, urinary retention (anticholinergic)</li>
          <li>Hypotension (more likely with IV/rapid administration)</li>
          <li>Paradoxical agitation (uncommon)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Do not let antihistamine use delay epinephrine in true anaphylaxis</li>
          <li>Sedation can impair watchkeeping/workplace safety; document counsel</li>
          <li>Consider less-sedating alternatives for routine allergy symptoms when appropriate (e.g., cetirizine/loratadine)</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Documentation: pdf.hres.ca/dpd_pm/00072460.PDF (Health Canada product monograph: diphenhydramine injection)</li>
          <li>Documentation: handbook.bcehs.ca/drug-monographs/diphenhydramine/ (practical monograph)</li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
